Pluri (PLUR) Free Cash Flow (2010 - 2025)
Pluri (PLUR) reported Free Cash Flow of -$5.7 million for Q4 2025, down 19.24% year-over-year from -$7.0 million in Q4 2024, and down 1.95% quarter-over-quarter from -$5.5 million in Q3 2025.
Pluri (PLUR) Free Cash Flow (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 16 years of Free Cash Flow data on file, last reported at -$5.7 million in Q4 2025.
- Free Cash Flow for Q4 2025 came in at -$5.7 million, down 19.24% year-over-year; the trailing twelve-month figure through Dec 2025 was -$22.0 million (down 24.89% YoY), and the FY2025 annual result was -$19.8 million, down 8.1% from the prior year.
- Free Cash Flow declined to -$5.7 million in Q4 2025 per PLUR's latest filing, from -$5.5 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$3.0 million in Q2 2023 and troughed at -$9.9 million in Q4 2021.
- A 5-year average of -$6.3 million and a median of -$5.9 million in 2023 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2021 and 2023: Free Cash Flow slumped 47.39% in 2021, then jumped 65.29% in 2023.
- A 5-year view of Free Cash Flow shows it stood at -$9.9 million in 2021, then soared by 35.83% to -$6.3 million in 2022, then surged by 40.61% to -$3.8 million in 2023, then slipped by 25.73% to -$4.7 million in 2024, then retreated by 19.24% to -$5.7 million in 2025.
- Business Quant data shows PLUR's Free Cash Flow at -$5.7 million in Q4 2025, -$5.5 million in Q3 2025, and -$5.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 63,220.27 |
| 10 | Pluri | 21.85 Mn | 22.34 Mn | 86,000.00 | -5.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.65 Mn |
| Dec 31, 2025 | -5.65 Mn |
| Sep 30, 2025 | -5.54 Mn |
| Sep 30, 2025 | -5.54 Mn |
| Jun 30, 2025 | -5.94 Mn |
| Jun 30, 2025 | -5.94 Mn |
| Mar 31, 2025 | -4.88 Mn |
| Mar 31, 2025 | -4.88 Mn |
| Dec 31, 2024 | -4.74 Mn |
| Dec 31, 2024 | -4.74 Mn |
| Sep 30, 2024 | -4.27 Mn |
| Sep 30, 2024 | -4.27 Mn |
| Jun 30, 2024 | -4.32 Mn |
| Jun 30, 2024 | -4.32 Mn |
| Mar 31, 2024 | -4.29 Mn |
| Mar 31, 2024 | -4.29 Mn |
| Dec 31, 2023 | -3.77 Mn |
| Dec 31, 2023 | -3.77 Mn |
| Sep 30, 2023 | -5.96 Mn |
| Sep 30, 2023 | -5.96 Mn |